Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-18-009015
Filing Date
2018-02-14
Accepted
2018-02-14 17:08:52
Documents
1
Group Members
PETER KOLCHINSKY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tv485673_sc13ga.htm SC 13G/A 43650
  Complete submission text file 0001144204-18-009015.txt   45361
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-51477 | Film No.: 18613485
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116
Business Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001346824 (see all company filings)

EIN.: 830406777 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A